A study of differential protein expression in injured spinal cord tissue of rats to predict biomarkers of recovery following Intermittent Theta-Burst stimulation and iron oxide nanoparticles implantation
Implementing Organization
All India Institute of Medical Sciences
Principal Investigator
Prof. Suman Jain
All India Institute Of Medical Sciences (AIIMS), New Delhi
CO-Principal Investigator
Dr. Gururao Hariprasad
All India Institute Of Medical Sciences (AIIMS), New Delhi-110029, Dr. Kanwal Preet Kochhar, All India Institute Of Medical Sciences (AIIMS), New Delhi-110029, Dr. Punit Kaur, All India Institute Of Medical Sciences (AIIMS), New Delhi-110029, Prof. Amit Kumar Dinda, All India Institute Of Medical Sciences (AIIMS), New Delhi-110029
Project Overview
Traumatic spinal cord injury (SCI) is a great challenge for therapeutic management considering its high morbidity. In SCI patients, specific areas of the brain are stimulated using repetitive Transcranial Magnetic Stimulation (rTMS) or intermittent Theta Burst Stimualtion (iTBS) and shown partial improvement in sensory and motor function. A significant potentiation of the locomotor recovery and reduction in glial scarring was induced with implantation of IONPs at the lesion site and low-intensity whole body magnetic field exposure in complete SCI rats. The of the present study is to predict the therapeutic efficacy and identify the biomarkers of intermittent theta-burst stimulation with IONPs implantation in spinal cord injury. We hypothesize that administration of iTBS with IONPs at lesion site would alter the proteome expression to induce functional recovery. The curative effect of the intervention in complete spinal cord injured (SCI) rats will be assessed by behavioural (BBB locomotor score), electrophysiological (corticospinal excitability) and morphological (lesion volume) techniques. Protein profiling of the injured spinal cord tissue using mass spectrometry will give insight into the protein dynamics following the intervention. Further to identify proteins that can be used as signatures for recovery, PIs would correlate the functional data with proteomics. The knowledge imparted from the study is a first step towards deciphering potential biomarkers in human SCI patients following iTBS and IONPs intervention as well as guiding physicians in designing patient-oriented strategies.
Source
Source
Science and Engineering Research Board (SERB), DST 2022-23
Science and Engineering Research Board (SERB), New Delhi
Quick Information
Area of Research
Life Sciences & Biotechnology
Start Date
2022
End Date
2025
Status
Completed
Contact
sumanjain10@gmail.com
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
00
Publications
00
No. of Patents
Filed :00
Grant :00
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.